Latest News-LUNIT INC Mediaroom_Page

Lunit Files Registration Statement for Initial Public Offering

* First Korean healthcare company to obtain "AA-AA" ratings in technology assessment for its FDA-...

2022-06-16 21:00 2522

New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment

* Lunit to showcase 7 poster presentations and 4 online publications, the company's largest publi...

2022-05-27 08:30 2356

New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment

Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy as Diagnostic Aid in Cancer Treatment-Published in the European Journal of Cancer

* Study findings show that Lunit's AI-powered PD-L1 TPS analyzer minimizes interpretation discrep...

2022-05-19 21:00 1298

Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting

* 7 poster presentations and 4 online publications, including research on AI biomarkers, have bee...

2022-04-28 21:33 1621

Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting

Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ

* Lunit gets greenlight to accelerate listing on the KOSDAQ market * First Korean healthcare com...

2022-04-21 22:12 1804

New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities

* Lunit to present two abstracts about its AI-biomarker for immunotherapy, Lunit SCOPE IO * Lun...

2022-04-06 21:44 1882

New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

* Lunit's latest study provides evidence for Lunit SCOPE IO's ability to predict immunotherapy re...

2022-03-16 21:09 1987

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

Baheya Foundation, Egypt's Premier Destination for Breast Cancer, Adopts Lunit AI to Enhance Early Screening

SEOUL, South Korea, Jan. 18, 2022 /PRNewswire/ -- Lunit today announced a Reference Site Agreement ...

2022-01-18 13:00 1601

Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries

* Lunit meets MDSAP requirements as a global standard medical AI software manufacturer * QMS au...

2021-12-27 23:00 2410

Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- CB Insights today named L...

2021-12-09 11:24 2113

Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American...

2021-11-25 22:00 3361

Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance

SEOUL, South Korea, Nov. 18, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today annou...

2021-11-18 22:00 1847

Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance

Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases

- First FDA 510(k) clearance from its AI software product lineup for radiology, specialized in tria...

2021-11-15 23:33 1729

Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases

Lunit Presents Studies at SITC 2021, Highlighting the Effectiveness of AI in Predicting Response to Immunotherapy in a Clinical Trial Setting

- Lunit to present three abstracts about its AI biomarker platform Lunit SCOPE IO, also to be dem...

2021-11-11 23:00 1450

Latest News